About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, October 20th, 2014

The QualityStocks
Daily Stock List


Wellness Center USA, Inc. (WCUI)

PennyStocks24, Pumps and Dumps, UndiscoveredEquities, StockProfessors, PennyStockShark, and USA Market News reported previously on Wellness Center USA, Inc. (WCUI), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Wellness Center USA, Inc. is an alternative healthcare, medical device solutions, and online nutraceutical sales company. It has four business units. These are Stealth Mark (SMI), AminoFactory, Psoria-Shield, Inc. (PSI), and National Pain Centers, Inc. (NPC). Wellness Center USA has its corporate headquarters in Schaumburg, Illinois. The Company’s shares trade on the OTC Markets’ OTCQB.

Wellness Center USA specializes in the development of Healthcare and Alternative Care solutions that improve life across North America and other developing markets. Its SMI business unit is a global product authentication solutions provider. SMI offers the most advanced product security technologies available today within the security and supply chain management vertical sectors.

SMI provides customers true brand protection from counterfeiting and diversion. This is while maintaining the integrity of product authentication. Its Stealth Mark® solutions are based upon encrypted microparticle technology, state-of-the-art printing technologies, and a reader that can be used with iPhone and other smartphones. 
National Pain Centers (NPC) concentrates on diagnosis, treatment, research, advocacy, education, and setting standards and protocols within interventional and multi-modal pain management. Moreover, Wellness Center USA’s AminoFactory is an online supplement store. It markets and sells an extensive range of high-quality nutritional vitamins and supplements. Through its online store (AminoFactory.com), customers can browse and purchase vitamins and nutrition, muscle mass building, fat burning, exercise endurance and recovery, and sports related apparel products.

Psoria-Shield (PSI) specializes in the design, manufacturing, and distribution of medical devices to domestic and global markets. PSI's flagship product is Psoria-Light®. It is Food and Drug Administration (FDA)-cleared and CE marked.

Psoria-Light® delivers targeted UV phototherapy for the treatment of certain skin disorders. Psoria-Light® emits only pure monochromatic UVA and narrow-band UVB light from deep UV LED arrangements. The device's other LED emitter technology doesn't heat the skin and doesn't carry any of the laser-specific safety concerns associated with excimer lasers.

Wellness Center USA, Inc. (WCUI), closed Monday's trading session at $0.23, up 12.20%, on 631,844 volume with 116 trades. The average volume for the last 60 days is 128,165 and the stock's 52-week low/high is $0.1011/$0.80.

Tristar Wellness Solutions, Inc. (TWSI)

PennyStocks24, Otcstockexchange, WhisperFromWallStreet, Center Stage Stocks, Pennystocktweeters.com, Pumps and Dumps, MajorPennyStocks, Breaking Bulls, and Penny Pick Insider reported earlier on Tristar Wellness Solutions, Inc. (TWSI), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Westport, Connecticut-headquartered Tristar Wellness Solutions, Inc. is a consumer health and wellness company. It targets opportunities in the self-care and quality of life marketplace. The Company previously went by the name BioPack Environmental Solutions, Inc. It changed its name to TriStar Wellness Solutions, Inc. in January of 2013. The Company’s shares trade on the OTCQB.

Tristar has been built upon the Wound Care, Women’s Health and Therapeutic Skin Care product platforms. The Company has focused business development efforts on the Wound Care and Women’s Health platforms via a combination of strategic acquisitions and licensed technologies.

Regarding acquisitions, Tristar bought HemCon® Medical Technologies, Inc. in May of 2013. This purchase provided access to more than 70 U.S. and worldwide patents defining the core wound care technology in bleeding control. In March 2013, Tristar obtained an exclusive global license (Argentum® / Silverlon®) to market adapted professional products for the direct-to-consumer (DTC) wound care market.

Moreover, the Company signed an exclusive license agreement in June of 2012 (Beautè de Maman®). This led to the Asset Purchase Agreement concluded in February of last year.  This is a DTC natural products company. It was developed by a renowned obstetrician creating health and beauty products for pregnant and nursing women.

In addition, Tristar, in February 2013, acquired “Soft and Smooth”. This is a novel feminine protection under development.

In early September, its HemCon Medical Technologies subsidiary announced that it will be exclusively focusing its resources on marketing and sales, new product development and technological innovations, best of class regulatory and quality systems and upgrading all internal information systems, immediately.

In addition, HemCon Medical Technologies announced in mid-September that the revenue performance on its chitosan technology platform has increased by 39 percent. Furthermore, microdispersed oxidized cellulose raw material is up 22 percent year-to-date through August 2014.  Overall, Tristar Wellness Solutions expects third quarter revenues to exceed the prior year in excess of 50 percent and be in line with overall business expectations for this year.    

Tristar Wellness Solutions, Inc. (TWSI), closed Monday's trading session at $0.38, down 5.00%, on 10,648 volume with 7 trades. The average volume for the last 60 days is 6,597 and the stock's 52-week low/high is $0.10/$2.00.

Studio One Media, Inc. (SOMD)

SmarTrend Newsletters, SmallCapVoice, Jan Carroll, and FeedBlitz reported previously on Studio One Media, Inc. (SOMD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Studio One Media, Inc. is a diversified media and technology company. Its wholly-owned subsidiaries include MyStudio, Inc. and AfterMaster HD Audio Labs, Inc. Studio One Media’s operational offices are in Scottsdale, Arizona. The Company’s research, recording and mastering studios are in Hollywood, California. Studio One Media’s shares trade on the OTC Markets’ OTCQB.

Studio One Media and its subsidiaries involve in the development and commercialization of proprietary (patents issued and pending), leading-edge audio and video technologies for professional and consumer use. This includes MyStudio® HD Recording Studios, AfterMaster HD Audio™ and ProMaster HD audio™.

The Company has developed and commercialized several award winning, proprietary, cutting-edge audio and video technologies for professional and consumer use. It has entered into licensing agreements with Sony/ATV Music Publishing, Universal Music Publishing Group, EMI Music Publishing, BMG Chrysalis, and strategic relationships with industry leaders. These include Mark Burnett Productions, Guitar Center, as well as Simon Cowell's “The X Factor.” 

Earlier this year, Studio One Media entered into an agreement with ON Semiconductor Corp. (ONNN) to develop integrated circuits (ICs) utilizing Studio One’s award-winning AfterMaster™ audio technology and ON Semiconductor’s DSP product development expertise.

AfterMaster™ is an innovative audio technology. It was originally developed for the mastering, re-mastering, as well as processing of audio through AfterMaster HD Audio Labs, a subsidiary of Studio One Media.

The expectation is that the devices will offer an unprecedented level of audio clarity, depth and loudness for consumer electronic devices. These include headphones, televisions, sound bars, computers, home and car stereos, tablets and mobile phones.

The AfterMaster™ technology has been used by numerous leading musicians looking to create a fuller and richer sound quality than otherwise available in digital audio. AfterMaster Labs maintains five primary business units. These are professional music mastering, consumer electronics, online mastering, AfterMaster Recording and Mastering Studios and Audio Consulting services.

Studio One Media, Inc. (SOMD), closed Monday's trading session at $0.55, up 1.85%, on 195,025 volume with 79 trades. The average volume for the last 60 days is 67,341 and the stock's 52-week low/high is $0.165/$0.55.

The Pulse Network, Inc. (TPNI)

SmallCapVoice, PennyStocks24, Pumps and Dumps, OTCMagic, Winston Small Cap, and OTPicks reported on The Pulse Network, Inc. (TPNI), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

The Pulse Network, Inc. provides a cloud-based platform focusing on content marketing and event solutions. Furthermore, it produces its own branded content programs including online video productions. Moreover, The Pulse Network produces the Inbound Marketing Summit conference series that runs in New York, San Francisco, and Boston, and the Digital Pulse program which runs in Boston. The Pulse Network lists on the OTC Markets’ OTCQB.

The Company helps clients (ranging from Fortune 500 companies to small and mid-size companies) in increasing awareness, propelling lead generation, and improving client engagement through content and inbound marketing, social strategy, campaign management, and event registration and event marketing activities in the U.S. with a social and digital foundation.

The Pulse Network’s platform allows digital and event marketers to fast-track their social strategy and create engaging content; event organizers to drive audience and engagement; and public relations companies and professionals to reach targeted audiences with the Company’s original content. The Pulse Network offers a service to businesses to create a platform for delivering content, chiefly video, and written and curated content, integrated with digital, social media, and offline event strategies.

Regarding Content Creation, its team helps businesses integrate rich content and digital presence solutions to create engaging, educational information and grow a client community and marketplace. This is through the power of video-first content, with supporting text, podcast tools, social media and multi‐channel delivery.

Concerning Event Management, The Pulse Network provides a one-stop shop for all event management needs from marketing to sales to operations to technology. Its focus is on high-touch, highly interactive, engaging programs. Additionally, it offers Website Design, SEO Management, PPC Management, and Social Media Services.

The Pulse Network, in cooperation with SAP, announced in September 2013, the Customer Edge outpost. SAP is the market leader in enterprise application software. The Customer Edge is a multimedia resource for everything related to delivering engaging, profitable customer relationships - for marketers, sales professionals, and service executives. The Customer Edge has exclusive video content, feature articles, social feeds, as well as conversations.

Last week, The Pulse Network announced the acquisition of You Everywhere Now, Instant Customer and Traffic Geyser. You Everywhere Now, Instant Customer and Traffic Geyser (ICTG) are a marketing technology platform solution for small to medium business lead generation and customer acquisition. ICTG is the world's first completely integrated marketing and follow up automation software using email, SMS/text, direct to voicemail, video, as well as live webinars.

The Pulse Network, Inc. (TPNI), closed Monday's trading session at $0.08, up 45.45%, on 176,000 volume with 27 trades. The average volume for the last 60 days is 15,850 and the stock's 52-week low/high is $0.025/$0.29.

Ubiquity, Inc. (UBIQ)

The Online Investor reported previously on Ubiquity, Inc. (UBIQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ubiquity, Inc. is a technology development and licensing company. It has a broad portfolio of patents across multiple technology market verticals. The Company focuses in five specific areas with a strong portfolio of patents and intellectual property (IP). Ubiquity’s shares trade on the OTC Bulletin Board. The Company has its corporate headquarters in Irvine, California.

Ubiquity has developed an intuitive user interface making access to all content from any device in a simple, consistent format. The Company has enabled the search and identification of any object and image in all video and digital media, and has developed a platform for mobile transactions (this includes the integration of payments, money transfers, coupons and gifts).

Ubiquity’s products include Sprocket. The Sprocket is an industry-leading, intuitive, immersive consumer experience for all web-based activity. Sprocket allows for the personalization of all content, whether public or private, in a unique, accessible way.

Via Ubiquity Labs, the Company is taking advantage of an extensive portfolio of IP spanning Web 3.0, immersive advertising, video compression, content distribution, eCommerce, and mobile applications to support the commercialization of new technologies.

Moreover, WEAV is its patented web services platform. WEAV allows for the very easy integration and blending of web, mobile and video services in the cloud. Additionally, Ubiquity’s intention is to pursue strategic licensing opportunities.

Last month, Ubiquity announced its strategy to uplist the trading of its common stock from the OTC Bulletin Board to the NASDAQ stock market.

Chris Carmichael, Chief Executive Officer of Ubiquity, said, "We believe uplisting to NASDAQ will improve our visibility to investors, as well as to enhance the trading liquidity of our common stock. We believe our shareholders will benefit from this offering as it will allow us to continue to grow our company and drive shareholder value as we prepare for a future NASDAQ uplisting. Providing registration rights to our restricted stockholders will also mitigate the potential selling pressure that could complicate our proposed offering."

Ubiquity, Inc. (UBIQ), closed Monday's trading session at $3.07, up 12.45%, on 37,364 volume with 76 trades. The average volume for the last 60 days is 11,589 and the stock's 52-week low/high is $1.05/$10.00.

Spectral Capital Corp. (FCCN)

PennyStocks24, 007 Stock Chat, StockHideout, PennyStockSpy, OTPicks. SmallCapVoice, Otcstockexchange, Whisper from Wall Street, Damn Good Penny Picks, Penny Stock Newsletter, Penny Picks, and PREPUMP STOCKS reported earlier on Spectral Capital Corp. (FCCN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 2005, Spectral Capital Corp. acquires and partners with early stage technology companies that have the ability to grow into independent public companies.  It looks for patentable technology and it focuses on identifying markets in which a start up has the opportunity to significantly enhance or become a complete game changer. Seattle, Washington-based Spectral Capital lists on the OTCQB.   

Spectral Capital enters markets positioned for fast growth and unlimited potential. Its portfolio of technology start-ups includes Kontexto.  Kontexto is a technology enterprise, which provides software and services that acquire, analyze, and visualize streaming real time data. Kontexto either delivers these services as a final Software-as-a-Service (SaaS) solution or embedded in third party applications. Kontexto's flagship product is publishflow™.

In addition, Spectral Capital's portfolio includes Noot, Inc. Noot is a mobile technology company. It is the creator of "noot", a search engine for mobile smartphones. Noot is to help people easily find news, social media, and photos and video that matches their interests. The technology learns what users like and improves its results over time.

Spectral Capital announced in December 2013 that it completed the transaction to acquire majority control of Monitr. This includes all intellectual property (IP) and assets that the company has and will develop. Monitr has been developing its technology for a number of years, which integrates semantic processing, data analytics, real time search, and machine learning into one platform. Additionally, the platform will have a social media element. The initial product will be marketed to the financial industry.

Last month, Spectral Capital announced the private beta release of Monitr. The design of Monitr is for individual investors and financial organizations. It analyzes news, opinion and social media so as to quantify the aggregate sentiment and trends of equities across global markets. Monitr is available as a SaaS or through customized data feeds suitable for larger financial institutions as well as hedge funds engaged in algorithmic analysis of financial markets.

Spectral Capital Corp. (FCCN), closed Monday's trading session at $0.35, up 52.17%, on 103,007 volume with 22 trades. The average volume for the last 60 days is 25,057 and the stock's 52-week low/high is $0.15/$0.45.

Hybrid Coating Technologies, Inc. (HCTI)

PennyStocks24, StockMarketQuote.us, PennyStockPlayers, PennyStockClub, The Stock Scout, Penny Stock Pros, Penny Stock Circle, 1-2-3 Stock Alerts, Stock Twiter, Buzz Stocks, Planet Penny Stocks, Stock Shock and Awe, Fast Money Alerts, Penny Stock General, SecretStockPromo, and Stock Onion reported earlier on Hybrid Coating Technologies, Inc. (HCTI), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed Hybrid Coating Technologies, Inc. focuses on improving the quality and safety of coatings and paint for industrial and commercial customers worldwide. It is the exclusive licensee of Green Polyurethane™ coatings and paint. Green Polyurethane™ is also referred to as "HNIPU" (Hybrid Non-Isocyanate Polyurethane). Hybrid Coating Technologies has its corporate office in San Francisco, California

HNIPU is a "hybrid" material. It combines the high chemical resistance properties of epoxy and advanced durability and wear resistance properties of polyurethane.

Hybrid Coating Technologies’ world renowned head scientist is Dr. Oleg Figovsky. Dr. Figovsky is one of the most well-recognized and accomplished scientists and inventors in the nanotech field. He is the principal inventor of the Green Polyurethane™ platform technology. Dr. Figovsky has over 40 years of experience in the field of special coatings, adhesives, sealants, as well as corrosion protection. 
Green Polyurethane™ coatings and paint are the world's first-ever patent-protected polyurethane-based coatings and paint products that eliminate toxic isocyanates from the entire production process (licensed by Nanotech Industries, Inc.). Green Polyurethane™ can be applied in one coating in most cases.

Additionally, it provides the first sound solution to the environmental and health hazards associated with isocyanates in polyurethane. Green Polyurethane™ safety features allow it to be applied without the interruption of business because of public exposure. This creates an additional 30-60 percent savings on application costs for customers.

Hybrid Coating Technologies has expanded its technology with a new UV curing formulation. Its new formulation is the only non isocyanate UV curing polyurethane formulation in the world. This new formulation allows its floor coating products to fully cure within an hour instead of seven days, which is the normal industry standard. 

Hybrid Coating Technologies announced this past July that it is entering into the international wood protection coatings market. Its new patent allows for a major increase in the product's elongation characteristics of up to 300 percent while maintaining the same high quality mechanical and chemical resistant properties its products have a reputation for.

Hybrid Coating Technologies, Inc. (HCTI), closed Monday's trading session at $0.1079, down 0.74%, on 52,100 volume with 9 trades. The average volume for the last 60 days is 190,164 and the stock's 52-week low/high is $0.0701/$0.80.


The QualityStocks
Company Corner


Cannabics Pharmaceuticals, Inc. (CNBX)

The QualityStocks Daily Newsletter would like to spotlight Cannabics Pharmaceuticals, Inc. (CNBX). Today, Cannabics Pharmaceuticals, Inc. closed trading at $0.30, up 3.52%, on 350 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,308, and its 52-week low/high is $0.03/$1.40.

Cannabics Pharmaceuticals, Inc. announced today that it has received Government Certification from the Ministry of Health in Israel for the establishment of an advanced R&D laboratory dedicated to medical research in the field of cannabinoid science. The stated goal of Cannabics Pharmaceuticals is to be one of the first and few companies in the world to commercialize indication specific and clinically tested cannabis-based medical products.

Cannabics Pharmaceuticals, Inc. (CNBX) was founded in 2012 by a team of experts in the fields of molecular biology, cancer research and pharmacology, who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant.

Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR, contains a pure concentrate of cannabinoids derived from select cannabis strains, embedded in a sophisticated formulation which provides beneficial therapeutic effects for 10-12 hours upon a single oral administration.

The excipients of the proprietary Cannabics SR formulation are all certified food-grade ingredients and are free of artificial additives or chemical substances. Cannabics’ proprietary technologies are developed in certified laboratories and are licensed to certified manufacturers and distributors with adequate licenses in their local territories. Cannabics Pharmaceuticals itself does not manufacture, distribute, dispense or possess any controlled substances, including cannabis and cannabis-based preparations.

Co-founders Dr. Zohar Koren (CEO) and Dr. Eyal Ballan (CTO) guide the company’s operations with vast experience in business and pharmaceutical development, strategic consulting, venture capital, evolutionary and environmental sciences, anti-cancer drug development and molecular biology. Under their leadership, Cannabics Pharmaceuticals continues to develop its genetic and phenotipic database to provide superior treatments for incapacitating ailments for which there is no cure. Disclaimer

Cannabics Pharmaceuticals, Inc. Company Blog

Cannabics Pharmaceuticals, Inc. News:

Cannabics Pharmaceuticals, Inc. (CNBX) Receives Cannabinoid R&D Lab Certification in Israel

Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR

Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board

Oriens Travel and Hotel Management Corp. (OTHM)

The QualityStocks Daily Newsletter would like to spotlight Oriens Travel and Hotel Management Corp. (OTHM). Today, Oriens Travel and Hotel Management Corp. closed trading at $0.0003, even for the day, on 21,260,000 volume with 11 trades. The stock’s average daily volume over the past 60 days is 25,820,063, and its 52-week low/high is $0.0001/$0.002.

Oriens Travel and Hotel Management Corp. announced this past Friday, October 17th, 2014 (via corporate blog), that the Company has launched one of its two primary revenue generating initiatives ahead of schedule; property sales. As with the rental initiative, scheduled to begin November 2014, management didn't anticipate beginning to offer any of its properties for sale until the 1st of November. However, as a Senior Board Member explains, "Pereira just can't slow down. To him, he's not moving fast enough!"

Oriens Travel and Hotel Management Corp. (OTHM) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Oriens has four objectives:

1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Oriens Travel and Hotel Management Corp. Company Blog

Oriens Travel and Hotel Management Corp. News:

Oriens and E-Net Kick Off Second Revenue Initiative

Oriens & E-Net; the Next Steps

Oriens and E-Net Initiate Revenue Plan

WRIT Media Group, Inc. (WRIT)

The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRIT). Today, WRIT Media Group, Inc. closed trading at $0.04, up 233.33%, on 9,475 volume with 8 trades. The stock’s average daily volume over the past 60 days is 45,615, and its 52-week low/high is $0.0107/$0.50.

WRIT Media Group, Inc. (WRIT) is focused on expanding in the digital media industry. The holding company currently operates under two different divisions: content creation via Front Row Networks, and "retro" video gaming via Retro Infinity Inc. and Amiga Games Inc.

The company’s Front Row Networks subsidiary produces, acquires and distributes live concerts in 2D and 3D format for initial worldwide digital broadcast into digitally-enabled movie theaters. In addition to presenting live concerts to massive audiences at lower ticket prices, Front Row Networks will license the content for many different distribution channels and sell merchandize where the live concerts are exhibited. The subsidiary also secures and distributes non-concert alternative theatrical programming and aims to acquire the broadest range of rights for exclusive programming.

Retro Infinity specializes in licensing classic computer and console video game libraries and adapts and republishes the most popular titles for smartphones, modern game consoles, micro-consoles, PCs, and tablets. The company leverages platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.

Amiga Games Inc. shares resources with Retro Infinity to adapt and republish the most popular titles from the Amiga family of computers for smartphones, modern game consoles, micro-consoles, PCs, and tablets. WRIT Media Group leverages the Amiga brand along with game brands of the past and proprietary technologies to create new revenue from classic games that have proven their ability to sell very well.

Together with its subsidiaries, WRIT Media Group is well positioned to benefit from the market growth and increased demand for alternative theatrical, mobile, and interactive content. Disclaimer

WRIT Media Group, Inc. Company Blog

WRIT Media Group, Inc. News:

Retro Infinity Sponsors NASCAR Driver Carlos Contreras' Record-Breaking 99th Career Race

WRIT Media Group (WRIT) CEO Featured in Exclusive QualityStocks Interview

WRIT Media Announces Launch of Online Video Game Point of Sale Platforms

Intelligent Highway Solutions, Inc. (IHSI)

The QualityStocks Daily Newsletter would like to spotlight Intelligent Highway Solutions, Inc. (IHSI). Today, Intelligent Highway Solutions, Inc. closed trading at $0.035, up 16.67%, on 135,700 volume with 6 trades. The stock’s average daily volume over the past 60 days is 105,175, and its 52-week low/high is $0.025/$0.83.

Intelligent Highway Solutions, Inc. (IHSI) is a diversified technology-based electrical contracting company focused on the development and implementation of high and low voltage solutions across multiple platforms. Aside from years of business management and financing experience, IHSI’s executive team has more than 80 years of combined electrical background, creating the perfect backdrop and catalyst for the company’s recent entrance into the overlooked yet critical lighting segment of the billowing medical marijuana industry.

Through the development of proprietary wireless vehicle detection systems designed to make the nation's roadways more efficient, IHSI developed deep relationships with the transportation markets of local and state governments. These business relationships played a significant role in IHSI securing exclusive distribution rights to lighting systems developed by SCS Lighting Solutions, an engineering and electronics company specializing in solid state diode (SSD) lighting solutions.

The initial focus of the business relationship was for IHSI to offer SCS’s highly efficient, long-lasting lighting solutions to municipalities as a means to drastically reduce energy and maintenance costs. As a result, when the new business opportunity arrived to provide a low cost, energy efficient lighting technology for accelerating the growth of cannabis plants, IHSI already had the expertise and infrastructure needed to create a superior light for this specific purpose.

Currently estimated to generate annual sales of $1.5 billion in the U.S. alone, the medical marijuana industry is one of the world’s fastest growing markets. Leveraging a C-level team of electrical contractors backed by years of business management expertise, IHSI is positioned to cultivate sustainable growth in a key segment of the medical marijuana industry through its exclusive distribution rights to proprietary lighting systems designed to help legal cannabis growers reduce costs and improve yields. Disclaimer

Intelligent Highway Solutions, Inc. Company Blog

Intelligent Highway Solutions, Inc. News:

Intelligent Highway Solutions Announces Agreement With a Washington D.C. Based Government Relations Firm

Intelligent Highway Solutions Installs 300W Grow Light at Medical Cannabis Growing Facility to Enhance Greater Yields

Intelligent Highway Solutions Announces Successful Test of Cannabis Lights and Additional Testing to Produce Greater Yields With New Prototype of Grow Light

Falcon Crest Energy (FCEN)

The QualityStocks Daily Newsletter would like to spotlight Falcon Crest Energy (FCEN). Today, Falcon Crest Energy closed trading at $0.02, up 11.11%, on 36,619 volume with 9 trades. The stock’s average daily volume over the past 60 days is 37,983, and its 52-week low/high is $0.0005/$0.095.

Falcon Crest Energy (FCEN) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.

The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Falcon Crest Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.

Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Falcon Crest Energy has strategically added extensive technical guidance and field management experience.

Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Falcon Crest Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer

Falcon Crest Energy Company Blog

Falcon Crest Energy News:

Falcon Crest Names Michael Cvetanovic to Advisory Council

Falcon Crest Energy Announces Powder River Basin Leasehold Acquisition

Panther Energy Changes Name to Falcon Crest Energy

WordLogic Corp. (WLGC)

The QualityStocks Daily Newsletter would like to spotlight WordLogic Corp. (WLGC). Today, WordLogic Corp. closed trading at $0.067, up 3.08%, on 249,092 volume with 14 trades. The stock’s average daily volume over the past 60 days is 46,871, and its 52-week low/high is $0.0601/$0.26.

WordLogic Corp. (WLGC) leverages more than 10 years of advanced R&D to assume its position as a global leader in predictive text input technology. Backed by multiple patents and its predictive engine, WordLogic’s interface is revolutionizing the way individuals and businesses search and communicate on touch screen devices. Furthermore, WordLogic offers a range of licensing options of its technology and patent portfolio.

The company’s technology incorporates proprietary Gesturing™ and WordChunking™ features that accelerate typing speeds while reducing the effort needed for accuracy. This interface increased text input on mobile devices by five times, rapidly speeding communication via instant messaging, text messaging, captioning, email and information searching. The iKnowU® keyboard uses state-of-the-art patented technology that becomes more accurate with each use, constantly learning about the user’s style and preferences. Utilizing the WordChunking and Gesturing, iKnowU enables the user to chain together phrases and create whole sentences in a matter of seconds.

For the business realm, WordLogic has developed a unique cloud solution to fit the specific needs of multiple industry sectors, enabling enterprises to create a single cloud-based dictionary specific to the company’s realm of expertise or multiple dictionaries specific for individual specialties or departments. This cloud solution creates continuity for users across multiple devices, boosting accuracy and productivity. WordLogic Reach™ enables users to select and insert meeting plans, contact information, and calendar entries from other apps in the mobile device.

Frost & Sullivan recently recognized WordLogic as the recipient of the 2014 North American Enabling Technology Leadership Award for Predictive Keyboard Applications, saying, “WordLogic’s technically impressive product - WordLogic Predictive Engine and its associated products iKnowU® and Reach™ - offers key competitive advantages, such as market-leading word and phrase prediction capabilities, a context-aware advertising model; simpler integration, increased speed and accuracy; and reduced costs. Add to that the significant number of pending and issued patents and you can see how value a package of technology WordLogic has developed truly is.” Disclaimer

WordLogic Corp. Company Blog

WordLogic Corp. News:

WordLogic the Sale of Exclusive Rights to Legal Enterprise Solutions to Private Equity Group

WordLogic Files Patent Infringement Lawsuit Against TouchType Ltd., Makers of SwiftKey

WordLogic Announces Development of iOS 8 Version of Award-Winning iKnowU Keyboard

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $10.50, even for the day. The stock’s average daily volume over the past 60 days is 85, and its 52-week low/high is $5.20/$15.00.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Receives Notice of Allowance for Canadian Patent, Further Expanding Stem Cell Technology Platform

VistaGen Announces Reverse Stock Split

VistaGen Receives Notice of Allowance for Canadian Patent Expanding Stem Cell Technology Platform


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Real Pennies


The Online Investor

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251